Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 05 08 2020
accepted: 13 11 2020
pubmed: 16 12 2020
medline: 3 8 2021
entrez: 15 12 2020
Statut: ppublish

Résumé

People living with HIV have high burdens of chronic lung disease, lung cancers, and pulmonary infections despite antiretroviral therapy (ART). The rates of tobacco smoking by people living with HIV vastly exceed that of the general population. Furthermore, we showed that HIV can persist within the lung mucosa despite long-term ART. As CD8 T cell cytotoxicity is pivotal for controlling viral infections and eliminating defective cells, we explored the phenotypic and functional features of pulmonary versus peripheral blood CD8 T cells in ART-treated HIV

Identifiants

pubmed: 33318292
pii: jimmunol.2000916
doi: 10.4049/jimmunol.2000916
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-651

Subventions

Organisme : CIHR
ID : 153082
Pays : Canada

Informations de copyright

Copyright © 2021 by The American Association of Immunologists, Inc.

Auteurs

Oussama Meziane (O)

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Département des Sciences Biologiques, Université du Québec à Montréal, Montreal, Quebec H2X 1Y4, Canada.

Yulia Alexandrova (Y)

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Département des Sciences Biologiques, Université du Québec à Montréal, Montreal, Quebec H2X 1Y4, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, Quebec H3A 2B4, Canada.

Ronald Olivenstein (R)

Division of Respirology, Department of Medicine, McGill University, Montreal, Quebec H4A 3J1, Canada.

Franck P Dupuy (FP)

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.

Syim Salahuddin (S)

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Département des Sciences Biologiques, Université du Québec à Montréal, Montreal, Quebec H2X 1Y4, Canada.

Elaine Thomson (E)

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Département des Sciences Biologiques, Université du Québec à Montréal, Montreal, Quebec H2X 1Y4, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, Quebec H3A 2B4, Canada.

Marianna Orlova (M)

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.

Erwin Schurr (E)

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Department of Human Genetics, McGill University, Montreal, Quebec H3A 0C7, Canada.

Petronela Ancuta (P)

Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec H2X 0A9, Canada.
Département de Microbiologie, Infectiologie, et Immunologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.

Madeleine Durand (M)

Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec H2X 0A9, Canada.

Nicolas Chomont (N)

Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec H2X 0A9, Canada.
Département de Microbiologie, Infectiologie, et Immunologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.

Jérôme Estaquier (J)

Centre de Recherche du Centre Hospitalier Universitaire de Québec, Faculté de Médecine, Université Laval, Quebec City, Quebec G1V 4G2, Canada.

Nicole F Bernard (NF)

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Division of Experimental Medicine, McGill University, Montreal, Quebec H4A 3J1, Canada.
Division of Clinical Immunology, McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada; and.

Cecilia T Costiniuk (CT)

Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, Quebec H3A 2B4, Canada.
Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.
Division of Infectious Diseases, McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada.

Mohammad-Ali Jenabian (MA)

Département des Sciences Biologiques, Université du Québec à Montréal, Montreal, Quebec H2X 1Y4, Canada; jenabian.mohammad-ali@uqam.ca.
Department of Microbiology and Immunology, McGill University, Montreal, Quebec H3A 2B4, Canada.
Département de Microbiologie, Infectiologie, et Immunologie, Université de Montréal, Montreal, Quebec H3C 3J7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH